Loading clinical trials...
Loading clinical trials...
Randomized, Double-blind, Placebo-controlled, Single-dose Ascending Study for the Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7450 in Healthy Subjects.
Conditions
Interventions
HRS-7450 ；Placebo
Start Date
October 1, 2023
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
October 17, 2023
NCT05767437
NCT03898960
NCT06628700
NCT02827825
NCT03281590
NCT03417349
Lead Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions